“Effect of Medical Marijuana on Neurocognition and Escalation of Use”
This study will use a randomized controlled design to test whether patients who use medical marijuana, compared to a waitlist control group, experience a change in health outcomes (relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use disorders, neurocognitive impairments) or brain-based changes.
Drug - Medical Marijuana
Patients in this group can choose when, where, and how much medical marijuana to use.
Effect of Medical Marijuana on Neurocognition and Escalation of Use